| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.003 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |